clinical

Bharat Biotech gets a nod of regulators for trial phase-3 nose vaccines

New Delhi: Hyderabad-based drug maker Bharat Biotech has received regulatory approval to start a Phase I clinical trial to test…

3 years ago

Try carrying Sputnik M vaccines for teenagers to India: Dr. Reddy’s

Hyderabad: Reddy Laboratory on Friday said he was discussing with Indian drug regulators to bring Sputnik M Russia, Covid-19 vaccine…

3 years ago

DCGI approved the trial of the dose of Intrasal Bharat Biotech booster

New Delhi: Medication Controller General India (DCGI) on Friday gave permission to Bharat Biotech to trial in an intranasal amplifier…

3 years ago

Covishield, Covaxin provides a conditional market nod

New Delhi: Indian Drug Regulator, Drug Controller General of India (DCGI), on Thursday gave approval for the vaccine Covid regular…

3 years ago

Professor IMS-BHU gets a place in Taskforce European lab medicine

Varanasi: Virology and Head of Molecular Biology Unit, Institute of Medical Sciences, University of Banaras Hindu (IMS-BHU), Prof.Sunit Kumar Singh…

3 years ago

The cost of Revamp Medical College SCB rose with 1000 crore

Bhubaneswar: The first phase cost of rebuilding SCB Medical College and Hospital, Cuttack, has increased around RS 1,000 Crore after…

3 years ago

The first Indian MRNA homegrown vaccine was tested in the midst of a surge in Omicron: official source

New Delhi: The first MRNA Messenger vaccine in the country is expected to start a trial in humans in February.Pune-based…

3 years ago

See the use of rampant drugs, the government warns Molnupiravir

New Delhi: The use of molnupiravir anti-virus drugs has a risk that must be warned, health officials say it underlines…

3 years ago

Clarification on Molnupiravir Antivirus Medication: Doctor to ICMR

Bengaluru: The doctor has the top new antivirus drug molnupiravir, launched on January 3 to treat Covid-19, after recent comments…

3 years ago

India Starts the 2nd Generation Covid Vaccine Court of US Companies

Mumbai: A clinical study of the second generation Covid-19 vaccine candidate based in the US has begun in India.In an…

3 years ago